Showing 40,001 - 40,020 results of 63,008 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((we decrease) OR (mean decrease)) ))', query time: 1.21s Refine Results
  1. 40001
  2. 40002
  3. 40003
  4. 40004
  5. 40005

    Phase 2b study of evocalcet (KHK7580), a novel calcimimetic, in Japanese patients with secondary hyperparathyroidism undergoing hemodialysis: A randomized, double-blind, placebo-co... by Tadao Akizawa (316095)

    Published 2018
    “…</p><p>Results</p><p>In total, 152 HDSHPT were randomized. The mean ± standard deviation (median, interquartile range) of percent changes in iPTH from baseline to end of treatment were −8.40±25.43% (−12.16, 39.60), −10.56±22.86% (−14.24, 27.85), and −20.16±34.23% (−23.83, 39.05) in the evocalcet 0.5, 1, and 2 mg/day groups and 5.44±25.85% (3.52, 35.39) and −25.86±27.76% (−29.79, 34.15) in the placebo and cinacalcet groups, respectively. …”
  6. 40006

    Multiple endophenotypes exhibited by <i>bbs</i> mutants. by Calvin A. Mok (201207)

    Published 2011
    “…ANOVA with Tukey, *** p<0.001, n≥20. Data represent mean ± SD normalized against wild-type body length. …”
  7. 40007
  8. 40008
  9. 40009

    <b>Tirzepatide Associated with Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Cli... by Ellen M. Apperloo (20405468)

    Published 2025
    “…</p><p dir="ltr"><i>Results:</i> The adjusted (95% CI) mean percent change from baseline in UACR for tirzepatide 5, 10, or 15 mg compared with all pooled comparators was -19.3% (-25.5, -12.5), -22.0% (-28.1, -15.3) and -26.3 (-32.0, -20.0), respectively, at Week 40/42. …”
  10. 40010

    Image_2_Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.tif by Youdong Wan (14766238)

    Published 2023
    “…We collected feces from rats and analyzed them by 16S rRNA sequencing. …”
  11. 40011

    Image_1_Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.tif by Youdong Wan (14766238)

    Published 2023
    “…We collected feces from rats and analyzed them by 16S rRNA sequencing. …”
  12. 40012

    Table_1_Montelukast Improves Symptoms and Lung Function in Asthmatic Women Compared With Men.docx by Renata Esposito (7420730)

    Published 2019
    “…Interestingly, MS + ICS-treated women had significantly lower levels of blood eosinophils (from 5.27 ± 0.30 to 3.30 ± 0.31; p < 0.0449) and exhaled nitric oxide (from 44.70 ± 7.30 to 25.20 ± 3.90; p < 0.0294) compared with men.</p><p>Conclusion: The treatment with MS, added to ICS, in women leads to better control of symptoms, better management of lung function, and decreased inflammation levels compared with ICS + MS treatment in men.…”
  13. 40013

    Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

    Published 2010
    “…</b> Age pigment fluorescence measurements in wild-type animals raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates. We found that age pigment fluorescence decreases with increasing metformin concentration with the levels in the 50 mM group significantly lower than the controls (<i>P</i> = 0.0270 by an unpaired t test). …”
  14. 40014

    Co-localization between placental CS and SDC1 in third-trimester placental tissue. by Marina Ayres Pereira (3073296)

    Published 2016
    “…Scale bar represents 20 μm. (M) Addition of soluble CSA (sCSA) does not decrease the detection of SDC1 with CS chains (detected with an α-CS-56 antibody) in the placental tissue perfused with VAR2CSA-expressing parasites. …”
  15. 40015

    Data_Sheet_1_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.pdf by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”
  16. 40016

    Image_4_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”
  17. 40017

    Image_5_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”
  18. 40018

    Image_2_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”
  19. 40019

    Image_1_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”
  20. 40020

    Image_3_Hybrid Nanoparticles as an Efficient Porphyrin Delivery System for Cancer Cells to Enhance Photodynamic Therapy.TIF by Letícia B. Silva (11447653)

    Published 2021
    “…To overcome these challenges, we developed hybrid nanostructures to immobilize 5,10,15,20-tetrakis[(4-carboxyphenyl) thio-2,3,5,6-tetrafluorophenyl] (P), a new third-generation PS. …”